July 25, 2000JPI Jones Daniels
Pharmaceuticals Levoxyl Recalled
Louis, MO (SafetyAlerts) - The Food
and Drug Administration (FDA) today reported that Jones Pharma, Inc. is conducting a
recall of JPI Jones Daniels Pharmaceuticals Levoxyl because the milligram conversion on
the unit blisters is incorrectly declared as 0.75 mg.
JPI Jones Daniels Pharmaceuticals Levoxyl (Levothyroxine Sodium Tablets), 75 mcg (0.075
mg), Rx, packaged in unit-dose strips 10/10-tablet strips per box.
Recall #D-434-0. Class III
Lot #6221 EXP 02/01.
Daniels Pharmaceuticals, St. Petersburg, Florida.
Jones Pharma, Inc., St. Louis, Missouri, by telephone on May 8, 2000. Firm-initiated
recall ongoing. This is the first public notice issued by the FDA.
440 10/10-tablet strip boxes were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers July 25,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.